Antidiabetics,rapid actinginsulinspancreaticShake inhaler welland allow at least1min btw inhalations.Prime inhaler beforefirst use by releasing4 test sprays.Explain to pts that thismed controlshyperglycemia butdoes not curediabetes, therapy islong term.Pts w/DM should carrya source of sugar.Instruct pts on propertechniques for admin.Demonstratetechnique for mixinginsulins by drawingup insulin Aspart first.Treatment&prevention ofbronchospasmin asthma andCOPD.controlhyperglycemiain pts withT1/T2 DM.Binds to beta 2 adrenergicreceptors in airway smoothmuscle by inhibitingphosphorylation of myosinand decrease intracellularcalcium leads to relaxationof smooth muscle airways.Administersubq within 5-10min beforemeal. Rotateinjection sites.Basaglar,Lantus,ToujouInsulinGlargineInstruct ptsto contactHCPimmediatelyof SOB.Monitor pulmonaryfunction testbefore initiatingtherapy andperiodically duringtherapy.Do not draw up dose into asyringe from the kiwi pens,syringe markings do notmatch up and could lead tomedication error. Prior towithdrawing dose, rotatevial btw palms to ensureuniform solution; do notshae.Caution pt not toexceedrecommended dose,may cause adverseeffects or loss ofeffectiveness of med.onset iswithin 3to 4hrStimulate glucoseuptake in skeletalmuscle and fat,inhibit hepaticglucoseproduction.Assess for symptomsof hypoglycemia.Monitor body weightperiodically. Assess ptsfor signs of allergic rxn.Monitor glucose q6hduring therapy. Monitorserum K+ in pts at riskfor hypokalemia.antidiabetic,long-actinginsulinDo not mix insulinGlargine with otherinsulin. If giving witha short acting insulin,use separatesyringes and diffinjection sites.Observe forparadoxicalbronchospasm(wheezing). NotifyHCP immediately ifcondition occurs.Explain to pts that thismed controlshyperglycemia butdoes not curediabetes, therapy islong term.Pts w/DM should carrya source of sugar.SCAlbuterolSulfate NovologAssess for symptomsof hypoglycemia.Monitor body weightperiodically. Assess ptsfor signs of allergic rxn.Monitor glucose q6hduring therapy. Monitorserum K+ in pts at riskfor hypokalemia.PO/inhalationInsulinApartMonitor forhypokalemia asalbuterol maycause a decreasein serumpotassiumAssess lung sounds,pulse, BP beforeadmin and duringpeak of med. Noteamount, color, andcharacter of sputumproduced.Bronchodilators;adrenergicAdminister oralmed with mealsto minimizegastric irritationhypoglycemia,hypokalemia,erythema,lipodystrophy,pruritus,swelling.chest pain,palpitations,nervousness,restlessness, tremor,paradoxicalbronchospasmw/excessive use.Inform pts of unusualbad taste. Advise ptsto rinse mouth aftereach inhalation tominimize dry mouth.onset iswithin15minAntidiabetics,rapid actinginsulinspancreaticShake inhaler welland allow at least1min btw inhalations.Prime inhaler beforefirst use by releasing4 test sprays.Explain to pts that thismed controlshyperglycemia butdoes not curediabetes, therapy islong term.Pts w/DM should carrya source of sugar.Instruct pts on propertechniques for admin.Demonstratetechnique for mixinginsulins by drawingup insulin Aspart first.Treatment&prevention ofbronchospasmin asthma andCOPD.controlhyperglycemiain pts withT1/T2 DM.Binds to beta 2 adrenergicreceptors in airway smoothmuscle by inhibitingphosphorylation of myosinand decrease intracellularcalcium leads to relaxationof smooth muscle airways.Administersubq within 5-10min beforemeal. Rotateinjection sites.Basaglar,Lantus,ToujouInsulinGlargineInstruct ptsto contactHCPimmediatelyof SOB.Monitor pulmonaryfunction testbefore initiatingtherapy andperiodically duringtherapy.Do not draw up dose into asyringe from the kiwi pens,syringe markings do notmatch up and could lead tomedication error. Prior towithdrawing dose, rotatevial btw palms to ensureuniform solution; do notshae.Caution pt not toexceedrecommended dose,may cause adverseeffects or loss ofeffectiveness of med.onset iswithin 3to 4hrStimulate glucoseuptake in skeletalmuscle and fat,inhibit hepaticglucoseproduction.Assess for symptomsof hypoglycemia.Monitor body weightperiodically. Assess ptsfor signs of allergic rxn.Monitor glucose q6hduring therapy. Monitorserum K+ in pts at riskfor hypokalemia.antidiabetic,long-actinginsulinDo not mix insulinGlargine with otherinsulin. If giving witha short acting insulin,use separatesyringes and diffinjection sites.Observe forparadoxicalbronchospasm(wheezing). NotifyHCP immediately ifcondition occurs.Explain to pts that thismed controlshyperglycemia butdoes not curediabetes, therapy islong term.Pts w/DM should carrya source of sugar.SCAlbuterolSulfate NovologAssess for symptomsof hypoglycemia.Monitor body weightperiodically. Assess ptsfor signs of allergic rxn.Monitor glucose q6hduring therapy. Monitorserum K+ in pts at riskfor hypokalemia.PO/inhalationInsulinApartMonitor forhypokalemia asalbuterol maycause a decreasein serumpotassiumAssess lung sounds,pulse, BP beforeadmin and duringpeak of med. Noteamount, color, andcharacter of sputumproduced.Bronchodilators;adrenergicAdminister oralmed with mealsto minimizegastric irritationhypoglycemia,hypokalemia,erythema,lipodystrophy,pruritus,swelling.chest pain,palpitations,nervousness,restlessness, tremor,paradoxicalbronchospasmw/excessive use.Inform pts of unusualbad taste. Advise ptsto rinse mouth aftereach inhalation tominimize dry mouth.onset iswithin15min

Untitled Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
  1. Antidiabetics, rapid acting insulins
  2. pancreatic
  3. Shake inhaler well and allow at least 1min btw inhalations. Prime inhaler before first use by releasing 4 test sprays.
  4. Explain to pts that this med controls hyperglycemia but does not cure diabetes, therapy is long term. Pts w/DM should carry a source of sugar.
  5. Instruct pts on proper techniques for admin. Demonstrate technique for mixing insulins by drawing up insulin Aspart first.
  6. Treatment &prevention of bronchospasm in asthma and COPD.
  7. control hyperglycemia in pts with T1/T2 DM.
  8. Binds to beta 2 adrenergic receptors in airway smooth muscle by inhibiting phosphorylation of myosin and decrease intracellular calcium leads to relaxation of smooth muscle airways.
  9. Administer subq within 5-10min before meal. Rotate injection sites.
  10. Basaglar, Lantus, Toujou
  11. Insulin Glargine
  12. Instruct pts to contact HCP immediately of SOB.
  13. Monitor pulmonary function test before initiating therapy and periodically during therapy.
  14. Do not draw up dose into a syringe from the kiwi pens, syringe markings do not match up and could lead to medication error. Prior to withdrawing dose, rotate vial btw palms to ensure uniform solution; do not shae.
  15. Caution pt not to exceed recommended dose, may cause adverse effects or loss of effectiveness of med.
  16. onset is within 3 to 4hr
  17. Stimulate glucose uptake in skeletal muscle and fat, inhibit hepatic glucose production.
  18. Assess for symptoms of hypoglycemia. Monitor body weight periodically. Assess pts for signs of allergic rxn. Monitor glucose q6h during therapy. Monitor serum K+ in pts at risk for hypokalemia.
  19. antidiabetic, long-acting insulin
  20. Do not mix insulin Glargine with other insulin. If giving with a short acting insulin, use separate syringes and diff injection sites.
  21. Observe for paradoxical bronchospasm (wheezing). Notify HCP immediately if condition occurs.
  22. Explain to pts that this med controls hyperglycemia but does not cure diabetes, therapy is long term. Pts w/DM should carry a source of sugar.
  23. SC
  24. Albuterol Sulfate
  25. Novolog
  26. Assess for symptoms of hypoglycemia. Monitor body weight periodically. Assess pts for signs of allergic rxn. Monitor glucose q6h during therapy. Monitor serum K+ in pts at risk for hypokalemia.
  27. PO/inhalation
  28. Insulin Apart
  29. Monitor for hypokalemia as albuterol may cause a decrease in serum potassium
  30. Assess lung sounds, pulse, BP before admin and during peak of med. Note amount, color, and character of sputum produced.
  31. Bronchodilators; adrenergic
  32. Administer oral med with meals to minimize gastric irritation
  33. hypoglycemia, hypokalemia, erythema, lipodystrophy, pruritus, swelling.
  34. chest pain, palpitations, nervousness, restlessness, tremor, paradoxical bronchospasm w/excessive use.
  35. Inform pts of unusual bad taste. Advise pts to rinse mouth after each inhalation to minimize dry mouth.
  36. onset is within 15min